Balažiová Barbora, Kuková Zuzana, Mišíková Daša, Novosedlíková Katarína, Dallos Tomáš
Department of Pediatrics, National Institute for Children's Diseases, Comenius University Medical School in Bratislava, Bratislava, Slovakia.
Front Pediatr. 2022 Aug 12;10:956136. doi: 10.3389/fped.2022.956136. eCollection 2022.
Evidence-based recommendations for vaccination of patients with pediatric rheumatic diseases (PRDs) are available, their implementation in practice is unknown.
To analyze real-life vaccination coverage in children with PRDs and identify reasons for incomplete vaccination.
Up-to-date information on vaccination status of Slovak children followed at a tertiary pediatric rheumatology center was retrieved from pediatricians over an 18-month period and compared to the standard Slovak Immunization Schedule. Reasons for missed vaccinations were analyzed retrospectively.
Vaccination records of 156 patients (median age 10 years, 2-18) with PRDs (JIA = 108, systemic diseases = 21, autoinflammatory diseases = 16, uveitis = 9, others = 2) were available for analysis. 117 (75.0%) were completely vaccinated, 2 (1.3%) had not received any vaccine due to reasons unrelated to PRD. 37 (23.7%) remaining patients missed altogether 48 mandatory vaccinations. In 58.3% ( = 28, in 24 patients) no PRD related reasons for missing vaccinations were identified. Only 20 vaccinations (18 live-attenuated and 2 non-live in 19 patients) were missed due to ongoing immunosuppressive treatment or PRD activity. Patients aged 11-14 years were more likely to be incompletely vaccinated than other age groups (48.8% vs. 15.9%, < 0.001), mainly due to missed MMR booster. Systemic immunosuppressive treatment was a significant predictor for incomplete vaccination status (OR 5.03, 95% CI 1.13-22.31, = 0.03).
Full vaccination is possible in a high proportion of PRD patients. In addition to immunosuppressive therapy, reasons unrelated to PRDs are a frequent and possibly inadequate cause of missed vaccinations. Periodic vaccination status assessments are needed in pediatric rheumatology care.
针对小儿风湿性疾病(PRD)患者的疫苗接种已有循证建议,但在实际中的实施情况尚不清楚。
分析PRD患儿的实际疫苗接种覆盖率,并确定疫苗接种不完全的原因。
在18个月的时间里,从儿科医生处获取了斯洛伐克一家三级儿科风湿病中心随访的儿童疫苗接种状态的最新信息,并与斯洛伐克标准免疫规划进行比较。对错过疫苗接种的原因进行回顾性分析。
有156例PRD患者(中位年龄10岁,2 - 18岁)(幼年特发性关节炎 = 108例,全身性疾病 = 21例,自身炎症性疾病 = 16例,葡萄膜炎 = 9例,其他 = 2例)的疫苗接种记录可供分析。117例(75.0%)已完全接种疫苗,2例(1.3%)因与PRD无关的原因未接种任何疫苗。其余37例(23.7%)患者共错过48剂强制性疫苗接种。在58.3%( = 28例,涉及24名患者)的病例中,未发现与PRD相关的错过疫苗接种的原因。仅20剂疫苗接种(19例患者中18剂减毒活疫苗和2剂非活疫苗)因正在进行的免疫抑制治疗或PRD活动而错过。11 - 14岁的患者比其他年龄组更有可能未完全接种疫苗(48.8%对15.9%, < 0.001),主要原因是错过麻疹、腮腺炎、风疹联合疫苗加强针。全身性免疫抑制治疗是未完全接种疫苗状态的一个重要预测因素(比值比5.03,95%置信区间1.13 - 22.31, = 0.03)。
高比例的PRD患者可以实现完全接种疫苗。除免疫抑制治疗外,与PRD无关的原因是错过疫苗接种的常见且可能不充分的原因。儿科风湿病护理中需要定期评估疫苗接种状态。